Clinical Trials of Hepatitis B Immune Globulin
- 3 August 1972
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 287 (5), 251-252
- https://doi.org/10.1056/nejm197208032870512
Abstract
The National Blood Resource Branch of the National Heart and Lung Institute initiated on July 1, 1972, controlled clinical studies to evaluate the efficacy of hepatitis B immune globulin (HBIC) for the prevention and treatment of hepatitis Type B. Three patient populations are being investigated: subjects with acute fulminant hepatitis; persons with a known, accidental parenteral exposure to hepatitis B antigen (HBAg) contained in blood or blood products; and patients and staff newly arrived on chronic renal-dialysis units. Co-ordinating centers have been established for each patient population to be studied. Working with these centers, in clinical trials investigators affiliated with . . .Keywords
This publication has 8 references indexed in Scilit:
- Risk of posttransfusion hepatitis in the United States. A prospective cooperative studyPublished by American Medical Association (AMA) ,1972
- Periarteritis Nodosa, Australia Antigen and Lymphatic LeukemiaNew England Journal of Medicine, 1972
- Viral hepatitis, type B (MS-2 strain) prevention with specific hepatitis B immune serum globulinPublished by American Medical Association (AMA) ,1971
- Prophylactic Gamma Globulin for Prevention of Endemic HepatitisArchives of Internal Medicine, 1971
- ASSOCIATION BETWEEN POLYARTERITIS AND AUSTRALIA ANTIGENThe Lancet, 1970
- Gamma-globulin in the prophylaxis of posttransfusion hepatitisJAMA, 1966
- AN EVALUATION OF IMMUNE SERUM GLOBULIN AS A PROPHYLACTIC AGENT AGAINST HOMOLOGOUS SERUM HEPATITISThe American Journal of the Medical Sciences, 1947
- POST-TRANSFUSION HEPATITIS IN BATTLE CASUALTIESJAMA, 1945